FindTrial
Sign In

Co-infection in patients hospitalised for COVID-19 infection.

Co-infection at the time of hospital admission in patients with COVID-19 infection

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/01/039829
Enrollment
500
Registered
2022-01-31
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere Health Condition 2: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

None listed

Sponsors

nil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Samples for culture (sputum,respiratory secretions,blood,stool,urine)on or within 48 hours of admission from patients that are COVID-19 positive

Exclusion criteria

Exclusion criteria: Samples for culture (sputum,respiratory secretions,blood,stool,urine)after 48 hours of admission or from patients that are COVID-19 negative

Design outcomes

Primary

MeasureTime frame
Various community acquired Co-infection in COVID -19 positive patients will be studied. The type of organisms causing infection will be studiedTimepoint: 2 days—

Secondary

MeasureTime frame
Various community acquired Co-infection in COVID -19 positive patients will be studied. The type of organisms causing infection will be studiedTimepoint: 2 days—

Countries

India

Contacts

Public ContactDr Susan Cherian

Bhabha Atomic Research Centre Hospital

cheriansusan@yahoo.com9833884370

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026